Philip Haeusser

Dr. Philip Haeusser is a physicist, computer scientist, and entrepreneur focused on AI-driven applications. As co-founder and Chief Technology Officer of Ablacon, he pioneered the development of Electrographic Flow (EGF) Mapping, which was commercialized as the FDA-cleared OptiMap™ System under Cortex, Inc., and acquired by Boston Scientific in 2025.

Philip earned his Ph.D. in computer science from the Technical University of Munich (TUM), specializing in deep learning and computer vision. He holds a Master’s degree in physics from the University of California, Santa Cruz, supported by a Fulbright scholarship.

A prominent science communicator, Dr. Haeusser has hosted popular science television programs and authored two bestselling science books.

Currently, Dr. Haeusser advises and invests in digital health and AI startups, bridging the gap between research innovation and clinical application.